Clinical Trial Update: A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcranial Magnetic Stimulation for Treatment Resistant Depression [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describing a randomized, double-blind comparison of NRX-101 vs placebo for adults with treatment-resistant depression, covering Phase 2 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• NRX-101 (dextromethorphan/quinidine)

Snippet

Sponsor: NeuroRx, Inc. | Conditions: Treatment Resistant Depression | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING